Epidermal growth factor receptor as a therapeutic target in veterinary oncology
Immunotherapy with autologous tumour antigen-coated microbeads (large multivalent immunogen), IL-2 and GM-CSF in dogs with spontaneous B-cell lymphoma
Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC)
Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft
Comparison of examination of thoracic radiographs and thoracic computed tomography in dogs with appendicular osteosarcoma
COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy*,†
5-Lipoxygenase expression in benign and malignant canine prostate tissues*
Comparison of cytoreductive efficacy among vincristine, cyclophosphamide and doxorubicine in dogs with lymphoma that received amulti-drug chemotherapy protocol by measuringminimal residual disease
Immunohistochemical expression of vascular endothelial growth factor (VEGF) in canine mammary gland tumours and in regional and distantmetastasis
Liposomal doxorubicin and daily fractionated palliative radiotherapy in advanced feline fibrosarcomas
Immunohistochemical detection of vascular endothelial growth factor (VEGF) and c-kit (CD117) in canine melanoma
The BH3 mimetic Obatoclax induces apoptosis and growth inhibition in human and canine neoplastic mast cells
Use of lomustine in suspected intracranial non-resectable tumours in dogs
Evaluation of angiogenesis markers and clinical outcome in lymphoma-bearing dogs
High mobility group B1 (HMGB1) proteins in dogs with lymphoma: analysis of serum levels and association with outcome following combination chemotherapy
The use of a vaccine targeting telomerase reverse transcriptase (TERT) in healthy dogs and in dogs affected by malignant lymphoma*
Workplace contamination with cytotoxic drugs in a veterinary hospital
Polo-like kinase-1 (Plk-1) as a novel drug target in canine and human neoplastic mast cells
NI-1: a novel caninemast cell line with a unique KITmutation and resistance against masatinib
The cytotoxic effect of masitinib (Masivet®) on a canine leukaemia cell line does not result from inhibition of the ABC-transporters P-gp and MRP-1
The use of temozolomide and doxorubicin in dogs with multicentric lymphoma resistant to multiple standard chemotherapy protocols
Canine lymphoma:morphometric analysis of cytological samples
Bone marrow examinations in Bernese Mountain Dogs with disseminated histiocytic sarcoma
Use of interstitial brachytherapy (iridium-192) for treatment of fibrosarcomas in cats: 252 cases (2000–2004)
Palliative radiation therapy in 100 dogs with appendicular osteosarcoma
Identification of a rare dog leucocyte antigen class II haplotype as a protective factor against canine mammary tumours
Diagnostic utility of heart rate and body temperature in dogs with pituitarymacro-adenomas, intra-axial forebrain tumours or pituitarymicro-adenomas